Tissue Extracts

Subscribe to Selected New Research on Tissue Extracts

539 relevant articles (10 outcomes, 44 trials/studies) found for this Bio-Agent

Description: Preparations made from animal tissues or organs (ANIMAL STRUCTURES). They usually contain many components, any one of which may be pharmacologically or physiologically active. Tissue extracts may contain specific, but uncharacterized factors or proteins with specific actions.

Also Known As:

Extracts, Tissue

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 314

Tissue Extracts: 539

Experts

1.	Brünner, Nils: 2 articles (01/2008 - 03/2007)
2.	Harbeck, Nadia: 2 articles (03/2007 - 01/2006)
3.	Schmitt, Manfred: 2 articles (03/2007 - 01/2006)
4.	Sweep, Fred C G J: 2 articles (03/2007 - 03/2006)
5.	Grebenchtchikov, N: 2 articles (07/2005 - 04/2000)
6.	Jensen, Vibeke: 1 article (01/2008)
7.	Schrohl, Anne Sofie: 1 article (01/2008)
8.	Christensen, Ib Jarle: 1 article (01/2008)
9.	Nielsen, Hans Jørgen: 1 article (01/2008)
10.	Sørensen, Nanna Møller: 1 article (01/2008)

Related Diseases

1.	Neoplasms (Cancer) 09/01/2007 - "CONCLUSION: In present study it was shown that 31P NMR spectroscopy of PCA tumor tissue extracts may be used as reliable method for the assessment of the level of oxygenation as well as changes in energy metabolism in the experimental tumors. " 03/01/1982 - "These studies utilized xenoantisera raised against a pool of lung tumor extracts which were exhaustively adsorbed with normal serum and tissue extracts. " 05/01/1973 - "Carcinoembryonic antigenic activity of tissue extracts: a quantitative study of malignant and benign neoplasms, cirrhotic liver, normal adult and fetal organs." 04/15/2009 - "PC levels were monitored noninvasively by (31)P MRS in tumors and by (1)H MRS in cell and tumor tissue extracts. " 01/01/2007 - "This is an important finding, since serum is a much more preferable material compared with tumor tissue extracts. " Order ALL the reference details at left...
2.	Carcinoma (Carcinomatosis) 04/01/1999 - "Changes in the protein concentrations in serum and tissue extracts of tumour-bearing rats suggest that all members of rat macroglobulin family are disturbed during the development of the Walker carcinoma, though only alpha2MG and alpha1PAG were substantially elevated." 01/01/1983 - "Approximately one-third of the patients gave significant reactions with gastrointestinal carcinoma extracts compared with normal tissue extracts. " 08/01/1982 - "Tissue extracts from 18 oral carcinomas were tested in the leukocyte migration capillary technique (LMCT) against autologous leukocytes and against leukocytes of healthy matched controls. " 11/01/2001 - "In this study we have analyzed the circulating forms of MMP-9 and MMP-2 in serum samples of patients with colon carcinoma, as well as the enzymatic activities present in tissue extracts from surgical fragments (primary tumor and its paired healthy tissue). " 04/01/1976 - "The reactivity in the LMCT was manifest at protein concentrations of 300 and 400 mug/ml. The study indicates that in contrast to the LMCT, the LMAT cannot be used for detection of TCMH towards allogeneic hypernephroma tissue extracts in patients with renal carcinoma." Order ALL the reference details at left...
3.	Inflammation 12/01/1979 - "Since local clearance of fibrin in vivo and fibrinolysis inhibitor activity from tissue extracts studied in vitro are more evident in TI mice than in AT mice, it appears that T cell fu;ction is important in modulating the tissue response during granulomatous inflammation." 03/07/2005 - "To identify pathogenic antigens relevant to immune-mediated granulomatous inflammation in sarcoidosis, we used a limited proteomics approach to detect tissue antigens that were poorly soluble in neutral detergent and resistant to protease digestion, consistent with the known biochemical properties of granuloma-inducing sarcoidosis tissue extracts. " 09/01/1986 - "Tissue extracts from maxillary mucosa (MM) and nasal polyp (NP) with non-atopic chronic inflammation were applied to DEAE-Sepharose, and hydrolytic activity of lysosomal proteases (cathepsins B and H) was measured by the fluorometric assay. " Order ALL the reference details at left...
4.	Fibrosis (Cirrhosis) 08/01/1996 - "METHODS: Tissue extracts containing DNA repair enzyme, O(6)-methylguanine-DNA methyltransferase, were prepared from liver biopsy samples from 41 patients with cirrhosis (10 viral (HBV and HCV), 17 alcohol and 14 autoimmune), 17 patients with non-cirrhotic diseased liver and 4 patients with histologically normal liver. " 10/01/1987 - "To determine whether histologic ABs reliably reflect asbestos fiber concentrations in asbestosis, we compared the concentration of ABs in histologic sections to concentrations of ABs and fibers in tissue extracts of 14 asbestos workers with nonspecific interstitial fibrosis. " 08/01/1996 - "Compared with untreated SHR or WKY, we found the following: (1) Systolic arterial pressure was normalized (P < .025) and LVH completely reversed (P < .025) in SHR, with no significant reduction in systolic arterial pressure or left ventricular mass in WKY; (2) morphometrically determined myocardial fibrosis in SHR was significantly reversed (P < .025) and associated with improved diastolic stiffness (P < .05), which was measured in the isolated heart by calculation of the stiffness constant of the myocardium; no significant changes occurred in WKY; (3) reversal of myocardial fibrosis was accompanied by an increase (P < .025) in myocardial matrix metalloproteinase 1 activity determined by degradation of [14C]collagen with myocardial tissue extracts after trypsin activation of myocardial promatrix metalloproteinase 1; matrix metalloproteinase 1 activity remained unchanged in WKY treated with lisinopril; and (4) systolic dysfunction, measured by a significantly (P < .025) diminished slope of the systolic stress-strain relation under isovolumic conditions of the left ventricle, was found in 110-week-old SHR, and it could be prevented by lisinopril treatment. " Order ALL the reference details at left...
5.	Pancreatic Neoplasms (Pancreatic Cancer) 09/01/1989 - "The original test used by Halliday and Miller was modified by substituting tissue extracts with purified tumor antigens (gastrointestinal cancer antigen [GICA]) with the aim of reducing false-positive results in the diagnosis of patients with early pancreatic cancer. " 01/01/1990 - "Identification of the peanut-agglutinin binding pancreatic cancer serum marker in pancreatic tissue extracts." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Antigens
2.	Tissue Inhibitor of Metalloproteinase-1
3.	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
4.	Matrix Metalloproteinase 1 (Interstitial Collagenase)
5.	Fibrin
6.	Trypsin
7.	Insulin Receptor Substrate Proteins
8.	CA-19-9 Antigen (CA 19-9 Antigen)
9.	Lisinopril (Prinivil)
10.	Protein Kinase C

Related Therapies and Procedures

1.	Injections
2.	Prostatectomy (Retropubic Prostatectomy)
3.	Neurosurgical Procedures
4.	Mammaplasty (Breast Reconstruction)
5.	Corneal Transplantation (Keratoplasty)

Best Treatments:
Research Summary Report
on Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 20112 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>